Escobida, Baby Boy .
HRN: 27-24-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
AMPICILLIN 500MG (VIAL)
06/02/2025
06/09/2025
IV
168mg
Q12hours
PSNB Sec To Maternal Fever
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes